Recent News: Vermillion Announces Publication of New Study Demonstrating Overa’s Greater Sensitivity in Detecting Ovarian Cancer Compared with ROMA, HE4 + CA125, and CA125 Alone

Our Products

How We’re Transforming Ovarian Cancer Detection

We concentrate our development of novel diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer.